Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
VEGFR2/KDR/Flk-1 Antibody (2C6), Alexa Fluor™ 350, Novus Biologicals™
Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP236429AF350
Description
VEGFR2/KDR/Flk-1 Monoclonal specifically detects VEGFR2/KDR/Flk-1 in Human samples. It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Flow (Cell Surface).Specifications
VEGFR2/KDR/Flk-1 | |
Monoclonal | |
Alexa Fluor 350 | |
50 mM sodium borate with 0.05% sodium azide | |
KDR | |
Partial recombinant human VEGFR2 protein (between amino acids 300-600) [UniProt# P35968]. | |
0.1 mL | |
Primary | |
Human | |
IgG1 κ |
Western Blot, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin) | |
2C6 | |
Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Flow (Cell Surface) | |
CD309, CD309 antigen, EC 2.7.10, EC 2.7.10.1, Fetal liver kinase 1, fetal liver kinase-1, FLK-1, FLK1tyrosine kinase growth factor receptor, Kinase insert domain receptor, kinase insert domain receptor (a type III receptor tyrosine kinase), Protein-tyrosine kinase receptor flk-1, soluble VEGFR2, vascular endothelial growth factor receptor 2, VEGFR, VEGFR2, VEGFR-2 | |
Mouse | |
Protein G purified | |
Angiogenesis, Apoptosis, Cancer, Cellular Markers, Cytoskeleton Markers, Endothelial Cell Markers, Hematopoietic Stem Cell Markers, HIF Target Genes, Hypoxia, Phospho Specific, Signal Transduction, Stem Cell Markers, Tumor Suppressors, Tyrosine Kinases | |
3791.0 | |
Store at 4°C in the dark. |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction